|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.34 USD | -2.25% |
|
-8.05% | +161.45% |
| Apr. 09 | Transcript : ADC Therapeutics SA - Special Call | |
| Apr. 04 | Sector Update: Health Care Stocks Slump Late Afternoon | MT |
ADC Therapeutics SA reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 69.56 million compared to USD 209.91 million a year ago. Net loss was USD 240.05 million compared to USD 157.13 million a year ago.
Basic loss per share from continuing operations was USD 2.94 compared to USD 2.01 a year ago. Diluted loss per share from continuing operations was USD 2.94 compared to USD 2.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +161.45% | 358M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ADC THERAPEUTICS SA 
